ArticleBMC public health2026
The analysis of the leukemia mortality rate and its temporal trends in China from 2004 to 2021.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn China, leukemia remains one of the top ten causes of death, and understanding its mortality trends is crucial for public health planning. This study analyzed the mortality trends of leukemia in China from 2004 to 2021, exploring differences by gender, age, and urban versus rural regions.
methodsMortality data from the "Chinese Death Cause Monitoring Results Datasets" (2004-2021) were analyzed using Joinpoint regression analysis, which identifies changes in trend slopes and provides insight into significant shifts in mortality rates. The study calculated the annual percent change (APC) and average annual percent change (AAPC) for the overall and subgroup mortality rates.
resultsThe analysis revealed a general decline in leukemia mortality over the 18-year study period. The age-standardized mortality rate (ASMR) for leukemia in China has decreased significantly from 4.492/10
conclusionBetween 2004 and 2021, the overall leukemia mortality rate in China showed a declining trend. However, significant disparities were observed between the genders and regions. Our findings suggest that future prevention and treatment efforts may need to pay increased attention to high-risk populations, such as those in rural areas and male individuals, to further reduce leukemia mortality rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.